Effects of U-74389G, a novel 21-aminosteroid, on small intestinal ischemia and reperfusion injury in horses

Nicholas J. Vatistas, Jack R. Snyder, Susan Hildebrand, Faye A. Harmon, Michael J. Woliner, Sean J. Barry, Jorge Nieto, Pegeen Henry, L. Reed Enos, David Magliano, Scott A. Brown, Christiana Drake

Research output: Contribution to journalArticle

21 Scopus citations

Abstract

Objective - To determine the effects of the 21-aminosteroid, U-74389G, on reperfusion of the equine jejunum, using total (WO) and partial (PVO) vascular occlusion during the ischemic period. Design - TVO: 16 healthy horses were randomly allotted to 3 groups - 4 horses received the vehicle alone, 6 horses received a low dosage (3 mg/kg of body weight), and 6 horses a high dosage (10 mg/kg) of U-74389G. PVO: 10 healthy horses were randomly allotted to 2 groups - 5 horses received the vehicle alone, and 5 horses received the low dosage (3 mg/kg) of U-74389G. Procedure - TVO was induced for 1 hour followed by 2 hours of reperfusion. During PVO, blood flow was reduced to 20% of baseline for 2 hours, followed by 2 hours of reperfusion. For both models, either the vehicle alone or the drug was given 15 minutes prior to reperfusion. Samples were obtained before, during, and after ischemia for determination of myeloperoxidase (MPO) activity, malondealdehyde (MDA) concentration, concentration of conjugated dienes (PVO experiment only), and morphometric analysis. Results - TVO: tissue concentration of MDA and MPO activity were not altered in any group by ischemia or reperfusion. During ischemia, mucosal volume and surface area were reduced. After reperfusion, no further reduction occurred. After initial decrease in submucosal volume during ischemia, there was a significant increase after reperfusion in the vehicle-only group (P < 0.05). PVO: there were no alterations in the concentration of either MDA or conjugated dienes. There was a significant increase in the activity of MPO during ischemia and reperfusion (P < 0.05). These effects were similar for the vehicle-only and drug groups. During ischemia, there was a significant decrease in mucosal surface area and volume (P < 0.05), that was continued during reperfusion for the vehicle-only group (P < 0.05). Submucosal volume increased during reperfusion (P < 0.05). Serosal volume was increased during ischemia and reperfusion. Conclusions and Clinical Relevance - Reduced blood flow during ischemia (PVO group) caused continued ioss in mucosal volume and surface area during reperfusion. At the dosage given, the 21-aminosteroid, U-74389G, was not effective in preventing continued reduction in mucosal volume and surface area after restoration of blood supply in the horses subjected to reduced blood flow.

Original languageEnglish (US)
Pages (from-to)762-770
Number of pages9
JournalAmerican Journal of Veterinary Research
Volume57
Issue number5
StatePublished - May 1996
Externally publishedYes

    Fingerprint

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Vatistas, N. J., Snyder, J. R., Hildebrand, S., Harmon, F. A., Woliner, M. J., Barry, S. J., Nieto, J., Henry, P., Enos, L. R., Magliano, D., Brown, S. A., & Drake, C. (1996). Effects of U-74389G, a novel 21-aminosteroid, on small intestinal ischemia and reperfusion injury in horses. American Journal of Veterinary Research, 57(5), 762-770.